Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.595    -0.04 (-1.52%)
Bid:
2.575
Ask:
2.59
Spread: 0.015 (0.583%)
Market Cap: $8.56b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

CIB 1Q2022 Condensed Separate Results

19 Apr 2022 07:00

RNS Number : 4911I
Commercial Intnl Bank (Egypt) SAE
15 April 2022
 

Click on, or paste the following link into your web browser, to view the associated PDF document

http://www.rns-pdf.londonstockexchange.com/rns/4911I_1-2022-4-15.pdf

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Balance Sheet as at March 31, 2022

 

 

 

Notes

Mar. 31, 2022

 

Dec. 31, 2021

 

 

 

EGP Thousands

 

EGP Thousands

 

 

Assets

 

 

 

 

 

 

Cash and balances at the central bank

8

30,471,454

 

43,385,222

 

 

Due from banks

9

120,898,421

 

79,991,287

 

 

Loans and advances to banks, net

11

364,470

 

312,216

 

 

Loans and advances to customers, net

12

157,575,938

 

144,765,808

 

 

Derivative financial instruments

 

884,030

 

225,376

 

 

Investments

 

 

 

 

 

 

- Financial Assets at Fair Value through P&L

13

1,648

 

240,987

 

 

- Financial Assets at Fair Value through OCI

13

179,382,229

 

192,390,931

 

 

- Amortized cost

13

20,139,599

 

20,318,767

 

 

- Investments in associates and subsidiaries

14

1,014,350

 

1,014,350

 

 

Other assets

15

9,554,515

 

11,141,917

 

 

Deferred tax assets (Liabilities)

 

308,421

 

460,026

 

 

Property and equipment

16

2,284,285

 

2,404,237

 

 

Total assets

 

522,879,360

 

496,651,124

 

 

Liabilities and equity

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Due to banks

17

3,695,888

 

862,759

 

 

Due to customers

18

427,654,058

 

406,100,916

 

 

Derivative financial instruments

 

243,629

 

265,265

 

 

Current tax liabilities

 

1,113,423

 

2,234,985

 

 

Other liabilities

19

12,133,075

 

8,021,310

 

 

Issued debt instruments

20

1,810,601

 

1,557,263

 

 

Other loans

 

6,176,776

 

5,140,782

 

 

Other Provisions

21

4,853,905

 

3,539,676

 

 

Total liabilities

 

457,681,355

 

427,722,956

 

 

Equity

 

 

 

 

 

 

Issued and paid up capital

 

19,825,134

 

19,702,418

 

 

Reserves

 

39,418,823

 

33,767,423

 

 

Reserve for employee stock ownership plan (ESOP)

 

1,346,705

 

1,674,392

 

 

Retained earnings *

 

4,607,343

 

13,783,935

 

 

Total equity and net profit for the period / year

 

65,198,005

 

68,928,168

 

 

Total liabilities and equity

 

522,879,360

 

496,651,124

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements .

 

 

 

 

 

 

(Review report attached)

 

 

 

 

 

*

Including net profit for the current period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

Sherif Samy

 

CEO & Managing Director

 

Chairman

 

          

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

           

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Income Statement for the period ended March 31, 2022

 

 

 

 

 

 

 

 

 

 

Notes

 

 

Mar. 31, 2022

 

 

 

 

Mar. 31, 2021

 

 

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

Interest and similar income

 

 

11,812,196

 

 

10,120,581

 

Interest and similar expense

 

 

(5,209,537)

 

 

(4,444,196)

 

Net interest income

 

 

6,602,659

 

 

5,676,385

 

 

 

 

 

 

 

 

 

Fee and commission income

 

 

1,191,476

 

 

844,128

 

Fee and commission expense

 

 

(514,635)

 

 

(333,561)

 

 

Net fee and commission income

 

 

676,841

 

 

510,567

 

 

 

 

 

 

 

 

 

Dividend income

 

 

37,800

 

 

91

 

Net trading income

5

 

716,066

 

 

112,718

 

Profits (Losses) on financial investments

13

 

1,021,334

 

 

493,655

 

Administrative expenses

 

 

(1,545,348)

 

 

(1,472,944)

 

Other operating (expenses) income

6

 

(1,425,498)

 

 

(526,604)

 

Impairment release (charges) for credit losses

 

 

40,525

 

 

(702,082)

 

Profit before income tax

 

 

6,124,379

 

 

4,091,786

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

(1,375,213)

 

 

(1,209,247)

 

Deferred tax assets (Liabilities)

 

 

(509,574)

 

 

(6,239)

 

Net profit for the period

 

 

4,239,592

 

 

2,876,300

 

 

 

 

 

 

 

 

 

Earning per share

7

 

 

 

 

 

 

Basic

 

 

1.90

 

 

1.29

 

Diluted

 

 

1.87

 

 

1.27

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

 

 

 

 

Sherif Samy

 

 

CEO & Managing Director

 

 

 

 

Chairman

 

         

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim statement of Comprehensive Income for the period ended March 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

Mar. 31, 2022

 

 

 

 

Mar. 31, 2021

 

 

 

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

 

 

Net profit for the period

 

 

4,239,592

 

 

2,876,300

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of debt instruments measured at fair value through other comprehensive income after income tax

 

 

(3,958,945)

 

 

(1,674,309)

 

 

Transferred from reserve on disposal of financial assets at fair value through OCI

 

 

(4,201)

 

 

(104,406)

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

 

 

101,561

 

 

(14,644)

 

 

Total comprehensive income for the period

 

 

378,007

 

 

1,082,941

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                 

 

Condensed Separate Interim Cash flows for the period ended March 31, 2022

 

 

 

 

 

 

 

Notes

Mar. 31, 2022

 

Mar. 31, 2021

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

Profit before income tax

 

6,124,379

 

4,091,786

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

 

 

Fixed assets depreciation

16

210,105

 

194,609

Impairment charge for credit losses (Loans and advances to customers and banks)

 

(147,259)

 

720,756

Other provisions charges

21

1,036,307

 

114,144

Impairment charge for credit losses (due from banks)

 

4,977

 

(4,030)

Impairment (Released) charge for credit losses (financial investments)

 

101,757

 

(14,644)

Impairment (Released) charge for other assets

 

(277,768)

 

12,676

Exchange revaluation differences for financial assets at fair value through OCI

 

63

 

23,042

Impairment (Released) charge financial assets at fair value through OCI

 

-

 

(72,957)

Utilization of other provisions

21

(156)

 

(43,518)

Other provisions no longer used

21

(385)

 

(5,872)

Exchange differences of other provisions

21

278,463

 

(15,271)

Losses (profits) from selling property and equipment

 

(50)

 

(1,250)

Losses (profits) from selling financial investments

13

(1,021,334)

 

(420,698)

Shares based payments

 

175,235

 

162,451

Operating losses (profits) before changes in operating assets and liabilities

 

6,484,334

 

4,741,224

 

 

 

 

 

Net decrease (increase) in assets and liabilities

 

 

 

 

Due from banks

 

25,542,432

 

(12,278,859)

Financial assets at fair value through P&L

13

239,339

 

18,839

Derivative financial instruments

 

(680,290)

 

(66,183)

Loans and advances to banks and customers

11 - 12

(12,715,125)

 

(2,173,587)

Other assets

 

1,851,768

 

(284,984)

Due to banks

17

2,833,129

 

(6,304,086)

Due to customers

18

21,553,142

 

25,076,047

Income tax obligations paid

 

(261,790)

 

(29,046)

Other liabilities

 

1,876,780

 

(236,449)

Net cash used in (generated from) operating activities

 

46,723,719

 

8,462,916

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

Proceeds (payments) for investment in associates.

 

-

 

(158,360)

Payment for purchases of property, equipment and branches constructions

 

(76,753)

 

(347,656)

Proceeds from selling property and equipment

 

50

 

1,250

Proceeds from redemption of financial assets at amortized cost

 

2,609,283

 

346,898

Payment for purchases of financial assets at amortized cost

 

(2,430,124)

 

(3,844)

Payment for purchases of financial assets at fair value through OCI

 

(68,194,467)

 

(55,216,492)

Proceeds from selling financial assets at fair value through OCI

 

78,071,439

 

34,497,956

Net cash generated from (used in) investing activities

 

9,979,428

 

(20,880,248)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash flows for the period ended March 31, 2022 (Cont.)

 

 

 

 

 

 

 

 

Mar. 31, 2022

 

Mar. 31, 2021

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

Received (Repaid) in long term loans

 

1,035,994

 

(14,410)

Dividend paid

 

(4,410,322)

 

(1,360,652)

Issued debt instruments

 

253,338

 

-

Capital increase

 

122,716

 

-

Net cash generated from (used in) financing activities

 

(2,998,274)

 

(1,375,062)

 

 

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalent during the period

 

53,704,873

 

(13,792,394)

Beginning balance of cash and cash equivalent

 

60,891,899

 

75,965,247

Cash and cash equivalent at the end of the period

 

114,596,772

 

62,172,853

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

Cash and balances at the central bank

 

30,471,454

 

21,580,813

Due from banks

 

120,943,837

 

97,088,303

Treasury bills and other governmental notes

10

40,371,415

 

52,339,135

Obligatory reserve balance with CBE

 

(26,030,335)

 

(15,671,568)

Due from banks with maturities more than three months

 

(10,245,456)

 

(40,498,431)

Treasury bills with maturity more than three months

 

(40,914,143)

 

(52,665,399)

Total cash and cash equivalent

 

114,596,772

 

62,172,853

'

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended March 31, 2021

 

 

 

 

 

Mar. 31, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

 

 

 

 

 

Beginning balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626

 

 

 

 

 

Capital increase

-

-

-

-

-

-

-

-

-

-

 

 

 

 

 

Transferred to reserves

-

514,939

8,420,479

-

1,094

-

-

(8,936,512)

-

-

 

 

 

 

 

Dividend paid

-

-

-

-

-

-

-

(1,360,652)

-

(1,360,652)

 

 

 

 

 

Net profit of the year

-

-

-

-

-

-

-

2,876,300

-

2,876,300

 

 

 

 

 

Transferred from reserve of financial assets at fair value through OCI

-

-

-

-

-

(104,406)

-

104,406

-

-

 

 

 

 

 

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

8,333

-

8,333

 

 

 

 

 

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(1,674,309)

-

-

-

(1,674,309)

 

 

 

 

 

Transferred (from) to bank risk reserve

-

-

-

-

-

-

2,718

(2,718)

-

-

 

 

 

 

 

ECL for impairment of debt instruments investments

-

-

-

-

-

(14,644)

-

-

-

(14,644)

 

 

 

 

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

162,451

162,451

 

 

 

 

 

Ending balance

14,776,813

3,293,074

33,186,137

1,549,445

16,000

2,177,628

9,141

3,166,768

1,227,099

59,402,105

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended March 31, 2022

 

 

 

 

 

 

 

 

 

 

Mar. 31, 2022

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

 

 

 

 

 

Beginning balance

19,702,418

3,293,074

28,260,532

1,549,445

16,000

639,231

9,141

13,783,935

1,674,392

68,928,168

 

 

 

 

 

Capital increase

122,716

-

502,922

-

-

-

-

-

(502,922)

122,716

 

 

 

 

 

Transferred to reserves

-

670,872

8,333,404

-

2,947

-

-

(9,007,223)

-

-

 

 

 

 

 

Dividend paid

-

-

-

-

-

-

-

(4,410,322)

-

(4,410,322)

 

 

 

 

 

Net profit of the year

-

-

-

-

-

-

-

4,239,592

-

4,239,592

 

 

 

 

 

Transferred from reserve on disposal of financial assets at fair value through OCI

-

-

-

-

-

(4,201)

-

4,201

-

-

 

 

 

 

 

 

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(3,958,945)

-

-

-

(3,958,945)

 

 

 

 

 

 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,840

(2,840)

-

-

 

 

 

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

101,561

-

-

-

101,561

 

 

 

 

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

175,235

175,235

 

 

 

 

 

 

 

 

Ending balance

19,825,134

3,963,946

37,096,858

1,549,445

18,947

(3,222,354)

11,981

4,607,343

1,346,705

65,198,005

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim Balance Sheet as at March 31, 2022

 

 

Notes

Mar. 31, 2022

 

Dec. 31, 2021

 

 

 

EGP Thousands

 

EGP Thousands

 

 

Assets

 

 

 

 

 

 

Cash and balances at the central bank

8

30,581,505

 

43,492,248

 

 

Due from banks

9

121,082,311

 

80,141,769

 

 

Loans and advances to banks, net

11

364,470

 

312,216

 

 

Loans and advances to customers, net

12

158,490,232

 

145,575,243

 

 

Derivative financial instruments

 

884,030

 

225,376

 

 

Investments

 

 

 

 

 

 

- Financial Assets at Fair Value through P&L

13

1,648

 

240,987

 

 

- Financial Assets at Fair Value through OCI

13

180,352,612

 

193,198,894

 

 

- Amortized cost

13

20,412,726

 

20,547,465

 

 

- Investments in associates

14

208,156

 

205,315

 

 

Other assets

15

9,618,567

 

11,207,128

 

 

Goodwill

26

127,211

 

137,525

 

 

Intangible assets

27

31,963

 

34,554

 

 

Deferred tax assets (Liabilities)

 

308,421

 

456,002

 

 

Property and equipment

16

2,352,247

 

2,461,116

 

 

Total assets

 

524,816,099

 

498,235,838

 

 

Liabilities and equity

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Due to banks

17

3,725,995

 

866,056

 

 

Due to customers

18

429,022,053

 

407,241,538

 

 

Derivative financial instruments

 

243,629

 

265,470

 

 

Current tax liabilities

 

1,113,423

 

2,234,985

 

 

Other liabilities

19

12,181,434

 

8,085,545

 

 

Issued debt instruments

20

1,810,601

 

1,557,263

 

 

Other loans

 

6,176,776

 

5,140,782

 

 

Other Provisions

21

4,855,636

 

3,541,462

 

 

Total liabilities

 

459,129,547

 

428,933,101

 

 

Equity

 

 

 

 

 

 

Issued and paid up capital

 

19,825,134

 

19,702,418

 

 

Reserves

 

39,481,063

 

33,774,990

 

 

Reserve for employee stock ownership plan (ESOP)

 

1,346,705

 

1,674,392

 

 

Retained earnings *

 

4,524,449

 

13,696,402

 

 

Total equity and net profit for the period / year

 

65,177,351

 

68,848,202

 

 

Minority interest

509,201

 

454,535

 

Total minority interest, equity and net profit for the period / year

 

65,686,552

 

69,302,737

 

 

Total liabilities and equity

 

524,816,099

 

498,235,838

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements .

 

 

 

 

 

 

(Review report attached)

 

 

 

 

 

*

Including net profit for the current period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

Sherif Samy

 

CEO & Managing Director

 

Chairman

 

          

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

            

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim Income Statement for the period ended March 31, 2022

 

 

 

 

 

 

 

 

 

Notes

 

 

Mar. 31, 2022

 

 

 

 

Mar. 31, 2021

 

 

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

Interest and similar income

 

 

12,006,043

 

 

10,121,709

 

Interest and similar expense

 

 

(5,288,771)

 

 

(4,444,196)

 

Net interest income

 

 

6,717,272

 

 

5,677,513

 

 

 

 

 

 

 

 

 

Fee and commission income

 

 

1,203,252

 

 

844,263

 

Fee and commission expense

 

 

(515,125)

 

 

(333,668)

 

Net fee and commission income

 

 

688,127

 

 

510,595

 

 

 

 

 

 

 

 

 

Dividend income

 

 

37,800

 

 

91

 

Net trading income

5

 

732,821

 

 

112,718

 

Profits (Losses) on financial investments

13

 

1,040,297

 

 

493,655

 

Administrative expenses

 

 

(1,670,887)

 

 

(1,475,077)

 

Other operating (expenses) income

6

 

(1,431,967)

 

 

(526,620)

 

Goodwill amortization

26

 

(10,314)

 

 

(10,314)

 

Intangible assets amortization

27

 

(2,591)

 

 

(2,591)

 

Impairment release (charges) for credit losses

 

 

38,692

 

 

(702,082)

 

Bank's share in the profits of associates

 

 

2,841

 

 

11,061

 

Profit before income tax

 

 

6,142,091

 

 

4,088,949

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

(1,372,939)

 

 

(1,209,247)

 

Deferred tax assets (Liabilities)

 

 

(509,534)

 

 

(6,239)

 

Net profit for the period

 

 

4,259,618

 

 

2,873,463

 

Minority interest

 

 

15,387

 

 

419

 

Bank shareholders

 

 

4,244,231

 

 

2,873,044

 

 

 

 

 

 

 

 

 

Earning per share

7

 

 

 

 

 

 

Basic

 

 

1.90

 

 

1.29

 

Diluted

 

 

1.87

 

 

1.27

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

 

 

 

 

Sherif Samy

 

 

CEO & Managing Director

 

 

 

 

Chairman

 

         

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim statement of Comprehensive Income for the period ended March 31 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

Mar. 31, 2022

 

 

 

 

Mar. 31, 2021

 

 

 

 

 

 

EGP Thousands

 

 

EGP Thousands

 

 

 

 

 

 

 

 

 

 

 

Net profit for the period

 

 

4,259,618

 

 

2,873,463

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of debt instruments measured at fair value through other comprehensive income after income tax

 

 

(3,961,167)

 

 

(1,674,309)

 

 

Transferred from reserve on disposal of financial assets at fair value through OCI

 

 

(4,201)

 

 

(104,406)

 

 

Cumulative foreign currencies translation differences

 

 

52,636

 

 

(3,320)

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

 

 

101,602

 

 

(14,644)

 

 

Total other comprehensive income

 

 

448,488

 

 

1,076,784

 

 

 

 

 

 

 

 

 

 

 

As follows:

 

 

 

 

 

 

 

 

Bank's shareholders

 

 

433,101

 

 

1,076,365

 

 

Minority interest

 

 

15,387

 

 

419

 

 

Total comprehensive income for the period

 

 

448,488

 

 

1,076,784

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim Cash flows for the period ended March 31 2022

 

 

 

 

 

 

Notes

Mar. 31, 2022

 

Mar. 31, 2021

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

Profit before income tax from continued operations

 

6,142,091

 

4,088,949

Adjustments to reconcile net profit to net cash provided by operating activities

 

 

 

 

Fixed assets depreciation

16

223,781

 

194,609

Impairment charge for credit losses (Loans and advances to customers and banks)

 

(145,266)

 

720,756

Other provisions charges

21

1,036,252

 

114,109

Impairment charge for credit losses (due from banks)

 

4,776

 

(4,030)

Impairment (Released) charge for credit losses (financial investments)

 

101,798

 

(14,644)

Impairment (Released) charge for other assets

 

(277,768)

 

12,676

Exchange revaluation differences for financial assets at fair value through OCI

 

63

 

23,042

Goodwill amortization

26

10,314

 

37,819

Intangible assets amortization

27

2,591

 

9,502

Impairment (Released) charge financial assets at fair value through OCI

 

-

 

(72,957)

Utilization of other provisions

21

(156)

 

(43,518)

Other provisions no longer used

21

(385)

 

(5,872)

Exchange differences of other provisions

21

278,463

 

(15,271)

Profits from selling property and equipment

 

(50)

 

(1,250)

Losses (profits) from selling financial investments

13

(1,040,297)

 

(420,698)

Shares based payments

 

175,235

 

162,451

Bank's share in the profits of associates

 

(2,841)

 

(11,061)

Operating losses (profits) before changes in operating assets and liabilities

 

6,508,601

 

4,774,612

 

 

 

 

 

Net decrease (increase) in assets and liabilities

 

 

 

 

Due from banks

 

25,468,271

 

(12,278,859)

Financial assets at fair value through P&L

13

239,339

 

18,839

Derivative financial instruments

 

(680,085)

 

(66,183)

Loans and advances to banks and customers

11 - 12

(12,821,977)

 

(2,178,284)

Other assets

 

1,844,416

 

(371,049)

Due to banks

17

2,859,939

 

(6,304,086)

Due to customers

18

21,780,515

 

25,079,066

Income tax obligations paid

 

(259,516)

 

(29,046)

Other liabilities

 

1,860,904

 

(25,774)

Net cash used in (generated from) operating activities

 

46,800,407

 

8,619,236

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

Proceeds (payments) for investment in associates.

 

-

 

(158,360)

Payment for purchases of property, equipment and branches constructions

 

(92,999)

 

(348,974)

Proceeds from selling property and equipment

 

50

 

1,250

Proceeds from redemption of financial assets at amortized cost

 

2,609,283

 

452,910

Payment for purchases of financial assets at amortized cost

 

(2,474,553)

 

(237,609)

Payment for purchases of financial assets at fair value through OCI

 

(68,625,535)

 

(55,600,830)

Proceeds from selling financial assets at fair value through OCI

 

78,456,150

 

33,585,657

Net cash generated from (used in) investing activities

 

9,872,396

 

(22,305,956)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim Cash flows for the period ended March 31, 2022 (Cont.)

 

 

 

 

 

 

 

 

Mar. 31, 2022

 

Mar. 31, 2021

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

Received (Repaid) in long term loans

 

1,035,994

 

(14,410)

Dividend paid

 

(4,410,322)

 

(1,360,652)

Issued debt instruments

 

253,338

 

-

Capital increase

 

122,716

 

-

Net cash generated from (used in) financing activities

 

(2,998,274)

 

(1,375,062)

 

 

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalent during the priod

 

53,674,529

 

(15,061,782)

Beginning balance of cash and cash equivalent

 

61,065,822

 

75,796,375

Cash and cash equivalent at the end of the period

 

114,740,351

 

60,734,593

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

Cash and balances at the central bank

 

30,581,505

 

21,800,293

Due from banks

 

121,128,084

 

97,518,428

Treasury bills and other governmental notes

10

40,379,000

 

52,371,207

Obligatory reserve balance with CBE

 

(26,188,639)

 

(15,805,888)

Due from banks with maturities more than three months

 

(10,245,456)

 

(42,484,048)

Treasury bills with maturity more than three months

 

(40,914,143)

 

(52,665,399)

Total cash and cash equivalent

 

114,740,351

 

60,734,593

'

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended March 31, 2021

 

 

 

 

 

Mar. 31, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders' Equity

Minority Interest

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

 

Beginning balance

14,776,813

2,778,135

24,765,658

1,549,445

8,183

14,906

3,975,514

6,423

10,539,715

1,064,648

(3,684)

59,475,756

483,055

59,958,811

 

Transferred to reserves

-

514,939

8,420,479

-

-

1,094

-

-

(8,936,512)

-

-

-

-

-

 

Dividend paid

-

-

-

-

-

-

-

-

(1,360,652)

-

-

(1,360,652)

-

(1,360,652)

 

Net profit of the year

-

-

-

-

-

-

-

-

2,873,044

-

-

2,873,044

419

2,873,463

 

Transferred from reserve of financial assets at fair value through OCI

-

-

-

-

-

-

(104,406)

-

104,406

-

-

-

-

-

 

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

-

8,333

-

-

8,333

-

8,333

 

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

-

(1,674,309)

-

-

-

-

(1,674,309)

-

(1,674,309)

 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

2,718

(2,718)

-

-

-

-

-

 

ECL for impairment of debt instruments investments

-

-

-

-

-

-

(14,644)

-

-

-

-

(14,644)

-

(14,644)

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

162,451

-

162,451

-

162,451

 

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

364

364

-

364

 

Balance at the end of the period

14,776,813

3,293,074

33,186,137

1,549,445

8,183

16,000

2,182,155

9,141

3,225,616

1,227,099

(3,320)

59,470,343

483,474

59,953,817

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended March 31, 2022

 

 

 

 

 

 

 

 

 

 

Mar. 31, 2022

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders' Equity

Minority Interest

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

 

Beginning balance

19,702,418

3,293,074

28,260,532

1,550,906

8,183

16,000

641,372

9,141

13,696,402

1,674,392

(4,218)

68,848,202

454,535

69,302,737

 

Capital increase

122,716

-

502,922

-

-

-

-

-

-

(502,922)

-

122,716

-

122,716

 

Transferred to reserves

-

670,872

8,333,404

-

-

2,947

-

-

(9,007,223)

-

-

-

-

-

 

Dividend paid

-

-

-

-

-

-

-

-

(4,410,322)

-

-

(4,410,322)

-

(4,410,322)

 

Net profit of the year

-

-

-

-

-

-

-

-

4,244,231

-

-

4,244,231

15,387

4,259,618

 

Transferred from reserve on disposal of financial assets at fair value through OCI

-

-

-

-

-

-

(4,201)

-

4,201

-

-

-

-

-

 

 

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

-

(3,961,167)

-

-

-

-

(3,961,167)

-

(3,961,167)

 

 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

2,840

(2,840)

-

-

-

-

-

 

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

-

101,602

-

-

-

-

101,602

-

101,602

 

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

175,235

-

175,235

-

175,235

 

 

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

56,854

56,854

39,279

96,133

 

Balance at the end of the period

19,825,134

3,963,946

37,096,858

1,550,906

8,183

18,947

(3,222,394)

11,981

4,524,449

1,346,705

52,636

65,177,351

509,201

65,686,552

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFGCGDSCDBDGDU
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.